tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

URGN Stock Latest News

UroGen Pharma initiated with a Buy at Guggenheim
The FlyUroGen Pharma initiated with a Buy at Guggenheim
3d ago
URGN
UroGen Pharma completes NDA submission for UGN-102
PremiumThe Fly
UroGen Pharma completes NDA submission for UGN-102
11d ago
URGN
UroGen Pharma says ahead of schedule to complete UGN-102 NDA
PremiumThe Fly
UroGen Pharma says ahead of schedule to complete UGN-102 NDA
12d ago
URGN
UroGen Pharma reports Q2 EPS (91c), consensus (83c)
PremiumThe Fly
UroGen Pharma reports Q2 EPS (91c), consensus (83c)
12d ago
URGN
Is URGN a Buy, Before Earnings?
PremiumPre-Earnings
Is URGN a Buy, Before Earnings?
14d ago
URGN
UroGen Pharma Shareholders Shape Governance and Incentives
PremiumCompany AnnouncementsUroGen Pharma Shareholders Shape Governance and Incentives
16d ago
8K
URGN
UroGen Pharma 5M share Spot Secondary priced at $17.50
Premium
The Fly
UroGen Pharma 5M share Spot Secondary priced at $17.50
2M ago
URGN
UroGen Pharma Announces Commencement of Public Offering of Ordinary Shares and Pre-Funded Warrants
Premium
Press Releases
UroGen Pharma Announces Commencement of Public Offering of Ordinary Shares and Pre-Funded Warrants
2M ago
URGN
UroGen Pharma announces offering of ordinary shares, warrants
PremiumThe Fly
UroGen Pharma announces offering of ordinary shares, warrants
2M ago
URGN
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
BPTH
CABA
UroGen Pharma price target raised to $40 from $32 at Oppenheimer
PremiumThe Fly
UroGen Pharma price target raised to $40 from $32 at Oppenheimer
2M ago
URGN
UroGen Pharma price target raised to $53.50 from $48 at Ladenburg
PremiumThe Fly
UroGen Pharma price target raised to $53.50 from $48 at Ladenburg
2M ago
URGN
UroGen Pharma price target raised to $60 from $54 at H.C. Wainwright
PremiumThe FlyUroGen Pharma price target raised to $60 from $54 at H.C. Wainwright
2M ago
URGN
UroGen Pharma trading resumes
Premium
The Fly
UroGen Pharma trading resumes
2M ago
URGN
UroGen Pharma’s Promising Trial Results and FDA Progress
Premium
Company Announcements
UroGen Pharma’s Promising Trial Results and FDA Progress
2M ago
8K
URGN
UroGen Pharma to resume trading at 11:15 am ET
PremiumThe Fly
UroGen Pharma to resume trading at 11:15 am ET
2M ago
URGN
UroGen reports 82.3% 12-month duration of response data from Phase 3 trial
PremiumThe Fly
UroGen reports 82.3% 12-month duration of response data from Phase 3 trial
2M ago
URGN
UroGen Pharma trading halted, news pending
PremiumThe Fly
UroGen Pharma trading halted, news pending
2M ago
URGN
UroGen Pharma announces David Lin as chief commercial officer
PremiumThe Fly
UroGen Pharma announces David Lin as chief commercial officer
3M ago
BMY
URGN
UroGen Pharma price target lowered to $32 from $34 at Oppenheimer
PremiumThe FlyUroGen Pharma price target lowered to $32 from $34 at Oppenheimer
3M ago
URGN
UroGen Pharma trading resumes
Premium
The Fly
UroGen Pharma trading resumes
3M ago
URGN
UroGen Pharma trading halted, volatility trading pause
Premium
The Fly
UroGen Pharma trading halted, volatility trading pause
3M ago
URGN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >